Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
- PMID: 32414417
- PMCID: PMC7228434
- DOI: 10.1186/s13054-020-02943-1
Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
Conflict of interest statement
The authors declare to have no competing interests.
Comment on
-
A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.Crit Care. 2020 Apr 2;24(1):128. doi: 10.1186/s13054-020-2836-4. Crit Care. 2020. PMID: 32241301 Free PMC article. No abstract available.
References
-
- Knaup H, Stahl K, Schmidt BMW, TO I, Busch M, Wiesner O, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22(1):285. doi: 10.1186/s13054-018-2220-9. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources